Midday Losers From November 7: Roka Bioscience, Salix Pharmaceuticals, Intercept Pharmaceuticals, Extended Stay America

Roka Bioscience Inc ROKA -52%; The company announced downbeat third quarter results Thursday; Bank of America downgraded the stock.

Salix Pharmaceuticals, Ltd. SLXP -32% - Late Thursday the company announced a negative accounting revision; Following the announcement analysts at multiple firms downgraded the stock and lowered the price target.

Intercept Pharmaceuticals Inc ICPT -31% - The company reported downbeat financial results; Leerink downgraded the stock; announced results from the FLINT trial evaluating obeticholic acid (OCA) for the treatment of nonalcoholic steatohepatitis (NASH) were published today in The Lancet.

Financial Engines Inc FNGN -22% - Shares are trending lower following downbeat financial results and a CEO change.

Extended Stay America Inc STAY -20% - The company announced financial results Friday morning, missing top and bottom line estimates.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: Intraday UpdateMovers
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!